Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2010
08/19/2010US20100210517 Cyclic receptor-associated protein (rap) peptides
08/19/2010US20100210476 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them
08/19/2010US20100209542 Methods For Treating Withdrawal From Addictive Compounds
08/19/2010US20100209541 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209520 Oral pharmaceutical preparation for colon-specific delivery
08/19/2010US20100209514 Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010US20100209510 Extended Release Formulation and Method of Treating Adrenergic Dysregulation
08/19/2010US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
08/19/2010US20100209498 Pharmaceutical compositions of duloxetine
08/19/2010US20100209489 Formulations of desvenlafaxine
08/19/2010US20100209488 Protein kinase modulating compounds and methods for making and using them
08/19/2010US20100209484 Transdermal Triptan Delivery System
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209461 Purified component of blue-green algae and method of use
08/19/2010US20100209459 Alkaloid formulations
08/19/2010US20100209449 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
08/19/2010US20100209434 Antibody formulation
08/19/2010US20100209425 Blood-Brain Barrier Targeting Anti-bodies
08/19/2010US20100209422 Antibodies specific for the protofibril form of beta-amyloid protein
08/19/2010US20100209417 Antibody Treatment of Alzheimer's and Related Diseases
08/19/2010US20100209408 Remodeling of Tissues and Organs
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209398 Compositions of stem cells and stem cell factors and methods for their use and manufacture
08/19/2010US20100209359 Medicated chewing gum
08/19/2010US20100209351 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
08/19/2010US20100209346 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof
08/19/2010US20100209345 Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors
08/19/2010DE102009008186A1 Feste orale pharmazeutische Zusammensetzung umfassend einen hydrophoben Wirkstoff A solid oral pharmaceutical composition comprising a hydrophobic drug
08/19/2010DE102009008185A1 Zusammensetzung umfassend einen hydrophoben Wirkstoff sowie ein Phospholipid A composition comprising a hydrophobic drug and a phospholipid
08/19/2010CA2789641A1 Diazepinedione derivative
08/19/2010CA2781830A1 Materials and methods for treating developmental disorders inclucing comorbid and idiopathic autism
08/19/2010CA2752269A1 Novel triazine derivative and pharmaceutical composition comprising the same
08/19/2010CA2752249A1 Products comprising n-phenylpropenoyl amino acid amides and uses thereof
08/19/2010CA2752237A1 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/19/2010CA2752156A1 4-(1-(3-(hydroxymethyl)-2-methylphenyl)ethyl)-1h-imidazole-2(3h)-thione
08/19/2010CA2752073A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/19/2010CA2751866A1 N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010CA2751863A1 N-[(2-azabicyclo[2.1.1]hex-1-yl]-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof
08/19/2010CA2751581A1 Compositions and methods for extended therapy with aminopyridines
08/19/2010CA2751260A1 Phenoxy acetic acid derivatives
08/19/2010CA2750913A1 Heterocyclic compounds, pharmaceutical compositions containing them, and their use as inhibitors of the glycine transporter 1
08/19/2010CA2750793A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/18/2010EP2218784A1 Vector(s) containing an inducible gene encoding a CDK4/CD6 inhibitor useful for treating neurodegenerative disorders
08/18/2010EP2218462A1 Pharmaceutical preparation for the treatment of depressive pathologies, comprising a protein with a high tryptophan/LNAAs (Large Neutral Amino Acids) ratio
08/18/2010EP2218450A1 Memantine for treating bipolar mood disorders resistant to conventional treatments
08/18/2010EP2218446A1 Method for producing microcapsule using solid fat
08/18/2010EP2217598A1 New tetracyclic compounds
08/18/2010EP2217597A1 Quinuclidin-4-ylmethyl 1h-indole-3-carboxylate derivatives as alpha 7 nicotinic acetylcholine receptor ligands for the treatment of alzheimer's disease
08/18/2010EP2217593A1 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor
08/18/2010EP2217583A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
08/18/2010EP2217575A1 Arylindenopyrimidines and their use as adenosine a2a receptor antagonists
08/18/2010EP2217564A1 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
08/18/2010EP2217562A2 Crystal forms of o-desmethylvenlafaxine fumarate
08/18/2010EP2217252A2 Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system
08/18/2010EP2217239A2 Modulation of protein trafficking
08/18/2010EP2217217A1 Controlled release pharmaceutical compositions of pregabalin
08/18/2010EP2058329B1 Improved secretion of neublastin
08/18/2010EP2013191B1 3,7-diamino-10h-phenothiazine salts and their use
08/18/2010EP1951692B1 Oxazole and thiazole ppar modulator
08/18/2010EP1940828B1 Heterocyclic aspartyl protease inhibitors
08/18/2010EP1858896B1 Diaza-spiro-[4.4]-nonane derivatives as neurokinin (nk1) antagonists
08/18/2010EP1743633B1 Use of a combination of theanine and serotonin for sleep disorders
08/18/2010EP1737842B1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
08/18/2010EP1692109B1 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
08/18/2010EP1682523B1 Morpholine derivatives as norepinephrine reuptake inhibitors
08/18/2010EP1644005B1 Metabolite of quetiapine
08/18/2010EP1611107B1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
08/18/2010EP1556068B1 Oxytocin for use in the treatment of Autism and Asperger's disorder
08/18/2010EP1451174B1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
08/18/2010EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
08/18/2010EP1320526B1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
08/18/2010EP1121115B2 Pufa supplements
08/18/2010CN1823803B Erigeron breviscapus injection preparation and its preparation method
08/18/2010CN1726039B Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
08/18/2010CN101809027A selective inhibitors of neurotensin degrading enzymes
08/18/2010CN101809021A octahydro-pyrrolo[3,4-b]pyrrole n-oxides
08/18/2010CN101809020A Perharidines as CDK inhibitors
08/18/2010CN101809019A Gamma secretase modulators
08/18/2010CN101809018A solids forms of ( s) -ethyl 2-amin0-3- (4- (2 -amino- 6- ( (r) -1- (4-chl0r0-2- o-methyl-ih-pyrazol- 1-yl) phenyl) -2, 2, 2-trifluorethoxy) -pyrimidin-4-yl) phenyl) propanoate
08/18/2010CN101809016A Gamma secretase modulators
08/18/2010CN101809015A Salts of a CGRP antagonist, method for producing the same and use thereof as drugs
08/18/2010CN101809000A Compounds with a combination of cannabinoid-CB1 antagonism and serotonin reuptake inhibition
08/18/2010CN101808999A Quinoline derivatives as 5HT5A receptor antagonists
08/18/2010CN101808987A New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
08/18/2010CN101808650A Composition and treatment
08/18/2010CN101808646A Agent for improving motor complications or psychiatric symptoms in parkinson's disease
08/18/2010CN101808635A Use of piperine and derivatives thereof for the therapy of neurological conditions
08/18/2010CN101805688A Mulberry health-care wine and preparation method thereof
08/18/2010CN101805686A Pine needle health-care wine
08/18/2010CN101805396A Anti-opioid peptide antagonist peptide and use thereof
08/18/2010CN101805390A Tripterine derivate and use thereof
08/18/2010CN101805340A Beta-chain simulative and correlation method thereof
08/18/2010CN101805309A Benzamide derivatives useful as histone deacetylase inhibitors
08/18/2010CN101805298A Novel aryl- and heteroarylpiperazines
08/18/2010CN101804205A Use of VEGF antibody and VEGF receptor antagonist in preparation of pain-killing vaccine or medicament
08/18/2010CN101804195A Medicinal simulation calculus bovis and manufacturing method thereof
08/18/2010CN101804190A Tongbi cream for relieving rigidity of muscles and promoting blood circulation and preparation method thereof
08/18/2010CN101804177A Anti-depressive traditional Chinese medicinal composition and dripping pill
1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 1833